LEXARIA BIOSCIENCE CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-08-31 was -102.67K shares.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-05-31 was 0.00 shares.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-02-29 was 102.67K shares.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-11-30 was 7.33K shares, a 97.78% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 7.33K shares, a 98.29% decline from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 430.00K shares, a 21.23% decline from fiscal 2018.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 545.88K shares, a 46.17% decline from fiscal 2017.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 1.01M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-08-31 | -102.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | 7.33K shares 10-K · filed 2021-11-29 |
| 2020-05-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | 110.00K shares derived: sum of 4 quarters · filed 2021-01-14 |
| 2020-02-29 | 102.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | |
| 2019-11-30 | 7.33K shares 10-Q · filed 2021-01-14 | |
| 2019-08-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | 430.00K shares 10-K · filed 2020-10-15 |
| 2018-11-30 | 330.00K shares 10-Q · filed 2019-01-11 | 820.88K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-08-31 | 247.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | 545.88K shares 10-K · filed 2019-11-14 |
| 2018-05-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | |
| 2018-02-28 | 243.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | |
| 2017-11-30 | 55.00K shares 10-Q · filed 2018-01-12 | |
| 2017-08-31 | 1.01M shares 10-K · filed 2018-11-14 | |
| 2011-10-31 | 106.25K shares 10-Q · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |